{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:18:49Z","timestamp":1787797129612,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dawn Program of the Shanghai Education Commission","award":["22SG36"],"award-info":[{"award-number":["22SG36"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-026-03884-2","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:10:50Z","timestamp":1781770250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of total en-bloc spondylectomy and separation surgery followed by stereotactic body radiotherapy for isolated spinal metastases in lung cancer patients: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhipeng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"1","key":"3884_CR1","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3884_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.spinee.2015.02.015","volume":"15","author":"GT Silva","year":"2015","unstructured":"Silva GT, Bergmann A, Thuler LC. Incidence, associated factors, and survival in metastatic spinal cord compression secondary to lung cancer. Spine J. 2015;15(6):1263\u20139.","journal-title":"Spine J"},{"issue":"21","key":"3884_CR3","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1056\/NEJMe2311559","volume":"389","author":"YL Wu","year":"2023","unstructured":"Wu YL, Zhou Q. Combination Therapy for EGFR-Mutated Lung Cancer. N Engl J Med. 2023;389(21):2005\u20137.","journal-title":"N Engl J Med"},{"key":"3884_CR4","doi-asserted-by":"publisher","first-page":"1357913","DOI":"10.3389\/fphar.2024.1357913","volume":"15","author":"J Ding","year":"2024","unstructured":"Ding J, et al. Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI. Front Pharmacol. 2024;15:1357913.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3884_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12885-019-5534-3","volume":"19","author":"YJ Cho","year":"2019","unstructured":"Cho YJ, et al. Clinical analysis of patients with skeletal metastasis of lung cancer. BMC Cancer. 2019;19(1):303.","journal-title":"BMC Cancer"},{"issue":"6","key":"3884_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01243894-200607000-00012","volume":"1","author":"TE Delea","year":"2006","unstructured":"Delea TE, et al. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol. 2006;1(6):571\u20136.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"3884_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.lungcan.2014.08.022","volume":"86","author":"K Cetin","year":"2014","unstructured":"Cetin K, et al. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. Lung Cancer. 2014;86(2):247\u201354.","journal-title":"Lung Cancer"},{"issue":"5","key":"3884_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2106\/JBJS.O.00629","volume":"98","author":"Y Tang","year":"2016","unstructured":"Tang Y, et al. Effect of Surgery on Quality of Life of Patients with Spinal Metastasis from Non-Small-Cell Lung Cancer. J Bone Joint Surg Am. 2016;98(5):396\u2013402.","journal-title":"J Bone Joint Surg Am"},{"key":"3884_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","volume":"148","author":"Y Lievens","year":"2020","unstructured":"Lievens Y, et al. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiother Oncol. 2020;148:157\u201366.","journal-title":"Radiother Oncol"},{"issue":"25","key":"3884_CR10","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, et al. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. J Clin Oncol. 2020;38(25):2830\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3884_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijrobp.2018.06.400","volume":"102","author":"WJ Petty","year":"2018","unstructured":"Petty WJ, et al. Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018;102(3):527\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3884_CR12","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar P, et al. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2018;4(1):e173501.","journal-title":"JAMA Oncol"},{"issue":"36","key":"3884_CR13","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1200\/JCO.22.01482","volume":"40","author":"W Liu","year":"2022","unstructured":"Liu W, Bahig H, Palma DA. Oligometastases: Emerging Evidence. J Clin Oncol. 2022;40(36):4250\u201360.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3884_CR14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1200\/JCO.2017.75.6536","volume":"36","author":"WA Stokes","year":"2018","unstructured":"Stokes WA, et al. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018;36(7):642\u201351.","journal-title":"J Clin Oncol"},{"key":"3884_CR15","doi-asserted-by":"publisher","first-page":"153303382211072","DOI":"10.1177\/15330338221107208","volume":"21","author":"RF Li","year":"2022","unstructured":"Li RF, et al. Separation Surgery in the Treatment of Spinal Metastasis. Technol Cancer Res Treat. 2022;21:15330338221107208.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"3884_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/2192568220919099","volume":"11","author":"W Xu","year":"2021","unstructured":"Xu W, et al. Massive Spondylectomy for Metastatic Spinal Cord Compression From Non-Small-Cell Lung Cancer With Local Failure After Radiotherapy. Global Spine J. 2021;11(4):549\u201355.","journal-title":"Global Spine J"},{"issue":"3","key":"3884_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jtho.2023.10.002","volume":"19","author":"CI Henschke","year":"2024","unstructured":"Henschke CI, et al. Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a-b; \u226420\u00a0mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery. J Thorac Oncol. 2024;19(3):476\u201390.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"3884_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, et al. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(4):249\u201374.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"3884_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.31616\/asj.2018.0145","volume":"13","author":"M Ohashi","year":"2019","unstructured":"Ohashi M, et al. En Bloc Spondylectomy for Spinal Metastases: Detailed Oncological Outcomes at a Minimum of 2 Years after Surgery. Asian Spine J. 2019;13(2):296\u2013304.","journal-title":"Asian Spine J"},{"issue":"10","key":"3884_CR20","doi-asserted-by":"publisher","first-page":"e1833","DOI":"10.1002\/onco.13840","volume":"26","author":"S Kato","year":"2021","unstructured":"Kato S, et al. Surgical Metastasectomy in the Spine: A Review Article. Oncologist. 2021;26(10):e1833\u201343.","journal-title":"Oncologist"},{"key":"3884_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clineuro.2018.04.007","volume":"170","author":"P Liu","year":"2018","unstructured":"Liu P, et al. Are older patients with solitary spinal metastases fit for total en-bloc surgery? Clin Neurol Neurosurg. 2018;170:20\u20136.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"3884_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4103\/0019-5413.185589","volume":"50","author":"SS Patil","year":"2016","unstructured":"Patil SS, Nene AM. Total enbloc spondylectomy for metastatic high grade spinal tumors: Early results. Indian J Orthop. 2016;50(4):352\u20138.","journal-title":"Indian J Orthop"},{"key":"3884_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.radonc.2021.08.011","volume":"164","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases. Radiother Oncol. 2021;164:98\u2013103.","journal-title":"Radiother Oncol"},{"issue":"3","key":"3884_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1227\/neu.0000000000002247","volume":"92","author":"VB Chakravarthy","year":"2023","unstructured":"Chakravarthy VB, et al. The Impact of Targetable Mutations on Clinical Outcomes of Metastatic Epidural Spinal Cord Compression in Patients With Non-Small-Cell Lung Cancer Treated With Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy). Neurosurgery. 2023;92(3):557\u201364.","journal-title":"Neurosurgery"},{"issue":"3","key":"3884_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/BSD.0000000000001057","volume":"34","author":"DC Kieser","year":"2021","unstructured":"Kieser DC, Parker J, Reynolds J. En Bloc Resection of Isolated Spinal Metastasis: A Systematic Review Update. Clin Spine Surg. 2021;34(3):103\u20136.","journal-title":"Clin Spine Surg"},{"issue":"1","key":"3884_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12957-024-03494-3","volume":"22","author":"K Zhang","year":"2024","unstructured":"Zhang K, et al. Efficacy and safety of en-bloc resection versus debulking for spinal tumor: a systematic review and meta-analysis. World J Surg Oncol. 2024;22(1):208.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"3884_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1302\/2633-1462.54.BJO-2024-0037.R1","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang S, et al. Effect of radiotherapy on local control and overall survival in spinal metastasis of non-small-cell lung cancer after surgery and systemic therapy. Bone Jt Open. 2024;5(4):350\u201360.","journal-title":"Bone Jt Open"},{"issue":"9","key":"3884_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","volume":"29","author":"DH Henry","year":"2011","unstructured":"Henry DH, et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol. 2011;29(9):1125\u201332.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3884_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jtho.2020.06.011","volume":"15","author":"S Peters","year":"2020","unstructured":"Peters S, et al. A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial. J Thorac Oncol. 2020;15(10):1647\u201356.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"3884_CR30","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/jnci\/djac015","volume":"115","author":"XS Wang","year":"2023","unstructured":"Wang XS, et al. Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer. J Natl Cancer Inst. 2023;115(6):742\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"3884_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djac016","volume":"115","author":"MT Milano","year":"2023","unstructured":"Milano MT, Salama JK, Chmura SJ. Should We Target Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer With Radiotherapy Before Administering Targeted Systemic Therapy? J Natl Cancer Inst. 2023;115(6):605\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"3884_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.6004\/jnccn.2021.7117","volume":"20","author":"JY Chang","year":"2022","unstructured":"Chang JY, Verma V. Optimize Local Therapy for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer to Enhance Survival. J Natl Compr Canc Netw. 2022;20(5):531\u20139.","journal-title":"J Natl Compr Canc Netw"},{"issue":"18","key":"3884_CR33","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019;37(18):1558\u201365.","journal-title":"J Clin Oncol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-026-03884-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03884-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:06:28Z","timestamp":1787796388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-026-03884-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3884"],"URL":"https:\/\/doi.org\/10.1186\/s12893-026-03884-2","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethical Committee of Changzheng Hospital, Second Military Medical University (2023SL050). Due to the retrospective nature of the study, the requirement for informed consent was waived, and all patient data were anonymized.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"579"}}